Development of In Vivo Models to Study Oncolytic Viral Therapies in Combination Treatments

Time: 8:35 am
day: Conference Day Two


• Overcoming the complexity of tumour biology and complex therapeutic interactions

• Spotlighting techniques to engineer mouse cell lines to better study oncolytic viruses

• Understanding strategies to combine oncolytic viruses with CAR-T cells for therapy